Journal details
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
SPRINGER · ISSN 1389-9155 · eISSN 1573-2606
SCIEScopusMEDLINEPubMedPMC
Overview
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. ISSN 1389-9155 · eISSN 1573-2606. published by SPRINGER. Netherlands. Endocrinology & Metabolism. impact factor 8.7 (2025). JCR Q1. CAS Zone 2. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 47 articles · 2025: 71 articles · 2024: 69 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of REVIEWS IN ENDOCRINE & METABOLIC DISORDERS?
The impact factor recorded for REVIEWS IN ENDOCRINE & METABOLIC DISORDERS is 8.7 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of REVIEWS IN ENDOCRINE & METABOLIC DISORDERS?
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS is listed in CAS Zone 2.
Which databases index REVIEWS IN ENDOCRINE & METABOLIC DISORDERS?
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.